A yeast two-hybrid technology-based system for the discovery of PPARγ agonist and antagonist
- 1 December 2004
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 335 (2) , 253-259
- https://doi.org/10.1016/j.ab.2004.09.004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Ligand and Coactivator Identity Determines the Requirement of the Charge Clamp for Coactivation of the Peroxisome Proliferator-activated Receptor γJournal of Biological Chemistry, 2003
- Target Genes of Peroxisome Proliferator-activated Receptor γ in Colorectal Cancer CellsJournal of Biological Chemistry, 2001
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 DiabetesBiochemical and Biophysical Research Communications, 2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Convergence of Transforming Growth Factor-β and Vitamin D Signaling Pathways on SMAD Transcriptional CoactivatorsScience, 1999
- N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 2. Structure−Activity Relationship and Optimization of the Phenyl Alkyl Ether MoietyJournal of Medicinal Chemistry, 1998
- Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγCell, 1998
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- α‐Galactosidase from Saccharomyces carlsbergensisEuropean Journal of Biochemistry, 1977